Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy

Tatsuo Kanda, Ryota Masuzaki, Naoki Matsumoto, Reina Sasaki-Tanaka, Hirofumi Kogure

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalHepatology Research
DOIs
Publication statusAccepted/In press - 2025

Keywords

  • DAA
  • decompensated cirrhosis
  • HCV
  • retreatment
  • sustained virologic response

Cite this